statistiche ricercatore

Continente	#
NA - Nord America	513
EU - Europa	340
AS - Asia	242
SA - Sud America	51
Continente sconosciuto - Info sul continente non disponibili	32
AF - Africa	16
Totale	1.194

Nazione	#
US - Stati Uniti d'America	490
IT - Italia	189
SG - Singapore	109
CN - Cina	44
BR - Brasile	43
DE - Germania	38
HK - Hong Kong	25
VN - Vietnam	24
RU - Federazione Russa	21
GB - Regno Unito	20
SE - Svezia	17
FR - Francia	15
NL - Olanda	13
BD - Bangladesh	11
CA - Canada	9
CI - Costa d'Avorio	8
IN - India	8
FI - Finlandia	7
JP - Giappone	6
ZA - Sudafrica	5
ES - Italia	4
PL - Polonia	4
AT - Austria	3
EC - Ecuador	3
GP - Guadalupe	3
MX - Messico	3
UZ - Uzbekistan	3
CL - Cile	2
GT - Guatemala	2
ID - Indonesia	2
IR - Iran	2
JM - Giamaica	2
JO - Giordania	2
LT - Lituania	2
PT - Portogallo	2
SA - Arabia Saudita	2
TR - Turchia	2
AE - Emirati Arabi Uniti	1
AR - Argentina	1
BG - Bulgaria	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
DZ - Algeria	1
ET - Etiopia	1
HU - Ungheria	1
IE - Irlanda	1
KE - Kenya	1
LC - Santa Lucia	1
LV - Lettonia	1
NI - Nicaragua	1
NO - Norvegia	1
PE - Perù	1
PK - Pakistan	1
VC - Saint Vincent e Grenadine	1
VE - Venezuela	1
Totale	1.163

Nome	#
Reazioni ritardate a farmaci: dal test di proliferazione linfocitaria alla desensibilizzazione.	219
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta‐analysis of eight studies	195
Desensitization in Iron Product Allergy	138
Two-year follow-up after drug desensitization in mucopolysaccharidosis	130
Acyclovir desensitization. A case report and a review of desensitization strategies	97
Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: A case report	93
How to manage hypersensitivity reactions to enzyme replacement therapy in lysosomal storage diseases?	86
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective Studies	77
null	64
Successful Treatment of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Tezepelumab: A Case Report	18
Perioperative hypersensitivity to cisatracurium: successful management with a rapid desensitization protocol	17
Dupilumab in the treatment of severe chronic rhinosinusitis with nasal polyps (CRSwNP) in cystic fibrosis patients	16
Rapid desensitization for human serum albumin (Grifols®) hypersensitivity	16
Successful rapid intravenous desensitization to rifampicin in a patient with tuberculosis	14
Dupilumab for the Treatment of Post-Scabies Prurigo (PSP): A Case Report	14
Totale	1.194

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	15	0	0	0	0	0	2	0	0	2	1	3	7
2022/2023	55	4	11	9	2	5	7	0	3	12	0	2	0
2023/2024	17	0	3	2	2	0	5	3	0	1	0	0	1
2024/2025	139	6	1	3	6	3	11	8	10	8	16	22	45
2025/2026	556	66	29	35	78	71	32	39	17	53	54	45	37
2026/2027	223	14	43	58	102	6	0	0	0	0	0	0	0
Totale													1.194